Health-related quality of life in cancer patients;Helbredsrelateret livskvalitet ved kræft

Ugeskrift for Laeger

Volumn 170, Issue 10, 2008, Pages 838-843

  Grønvold, Mogens ^a,b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; HEALTH STATUS; HUMAN; METHODOLOGY; NEOPLASM; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RESEARCH; REVIEW; SOCIOECONOMICS; STANDARD;

ADAPTATION, PSYCHOLOGICAL; HEALTH STATUS; HUMANS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH; SOCIOECONOMIC FACTORS;

EID: 41249086918     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
2. Fayers PM, Aaronson N, Bjordal K et al. The EORTC QLQ-C30 Scoring Manual 3rd edition. Brussels: European Organization for Research and Treatment of Cancer; 2001.
3. Cella DF, Tulsky DS, Gray G et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-9.
4. Schipper H, Clinch J, McMurray A et al. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 1984;2:472-83.
5. Spitzer WO, Dobson AJ, Hall J et al. Measuring the quality of life of cancer patients. A concise QL-index for use by physicians. J Chron Dis 1981;34:585-97.
6. de Haes JCJM, van Knippenberg FCE, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990;62:1034-8.
7. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.
8. Bjørner JB, Damsgaard MT, Watt T et al. Dansk manual til SF-36 - Et spørgeskema om helbredsstatus. København: Lif,1997.
9. Blazeby J, Sprangers M, Cull A et al. EORTC Quality of Life Group Guidelines for Developing Questionnaire Modules 3rd edition. Brussels: EORTC,2002:1-42.
10. Bottomley A, Aaronson NK. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience. J Clin Oncol 2007;25:5082-6.
11. Koller M, Aaronson NK, Blazeby J et al. Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer 2007;43:1810-20.
12. http://groups.eortc.be/qol /dec 2007.
13. Grønvold M, Petersen MA, Aaronson NK, et al. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 2006;42:55-64.
14. www.facit.org /dec 2007.
15. Fayers P, Bottomley A. Quality of life research within the EORTC - the EORTC QLQ-C30. Eur J Cancer 2002;38(suppl 4):125-33.
16. Lipscomb J, Gotay CC, Snyder C, red. Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005.
17. Lipscomb J, Reeve BB, Clauser SB, et al. Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol 2007;25:5133-40.
18. Brundage M, Osoba D, Bezjak A et al. Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:5078-81.
19. Bruner DW, Bryan CJ, Aaronson N et al. Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol 2007;25:5051-7.
20. Basch E, Iasonos A, Barz A, et al. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 2007;25:5374-80.
21. Bruner DW. Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials? J Clin Oncol 2007;25:5345-7.
22. Land SR, Ritter MW, Costantino JP et al. Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches. J Clin Oncol 2007;25:5113-20.
23. Efficace F, Osoba D, Gotay C et al. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Ann Oncol 2007;18:775-81.
24. Ganz PA, Gotay CC. Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions. J Clin Oncol 2007;25:5063-9.
25. Bruner DW, Bryan CJ, Aaronson N et al. Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol 2007;25:5051-7.
26. Sanders C, Egger M, Donovan J et al. Reporting on quality of life in randomised controlled trials: bibliographic study. Br Med J 1998;317:1191-4.
27. Ganz PA, Goodwin PJ. Quality of life in breast cancer - what have we learned and where do we go from here? I: Lipscomb J, Gotay CC, Snyder C, red. Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005:93-125.
28. Goodwin PJ, Black JT, Bordeleau LJ, et al. Health-related quality-of-life measurement in randomized clinical trials in breast cancer - taking stock. J Natl Cancer Inst 2003;95:263-81.
29. Mandelblatt J, Armetta C, Yabroff KR et al. Descriptive review of the literature on breast cancer outcomes: 1990 through 2000. J Natl Cancer Inst Monogr 2004;33:8-44.
30. Grønvold M, Strömgren LA. Symptomatologi blandt patienter, der modtager palliativ indsats - måling, forekomst og forløb. Ugeskr Læger 2007;169:3748-50.
31. Detmar SB, Muller MJ, Schornagel JH et al. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 2002;288:3027-34.
32. Velikova G, Booth L, Smith AB et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 2004;22:714-24.
33. Rosenbloom SK, Victorson DE, Hahn EA et al. Assessment is not enough: a randomized controlled trial of the effects of HRQL assessment on quality of life and satisfaction in oncology clinical practice. Psychooncology 2007;Mar 7 [epub ahead of print].
34. Coates A, Thomson D, McLeod GR et al. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 1993;29A:1731-4.
35. Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. Radiother Oncol 1989;15:235-42.
36. www.isoqol.org /dec 2007.
37. Efficace F, Bottomley A, Coens C et al. Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 2006;42:42-9.
38. Grønvold M Aa, Petersen MAa, Idler E et al. Psykisk velbefindende og træthed prædikterede risiko for recidiv og død efter brystkræft - sekundærpublikation. Ugeskr Læger 2008;170:844-7.